Close Menu

NEW YORK – Quanterix reported after the close of the market on Wednesday that its third quarter revenues rose 41 percent year over year, driven by an 80 percent increase in product revenues.

For the three months ended Sept. 30, the Billerica, Massachusetts-based company posted Q3 revenues of $14.9 million, up from $10.6 million in Q3 2018, beating the consensus Wall Street estimate of $12.6 million. Excluding $1.3 million recognized in Q3 2018 connected to the termination of a license agreement, revenue was up 62 percent year over year.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

A UK woman is suing three National Health Service Trusts for not telling her about her father's Huntington's disease diagnosis, the BBC reports.

LiveScience reports that a novel mutation in the LPL gene was uncovered in three siblings with very high triglyceride levels.

The president of Nankai University is embroiled in a data manipulation scandal, the South China Morning Post reports.

In PNAS this week: cytotoxic CD4 T cell signature in supercentenarians, evolutionary history of beetles, and more.